PRI-FLORECOL 23 ORAL LIQUID
Registered veterinary formulation (DRAP Reg: 122619)
Active: FUROSEMIDE (AS MONOETHANOLAMINE; SALT)------50MG; (BP SPECIFICATIONS); EACH LITER CONTAINS:-; FLORFENICOL----230GM; AS PER INNOVATOR''S SPECIFICATION; EACH ML CONTAINS:-
PRI-FLORECOL 23 ORAL LIQUID is a verified oral liquid developed and manufactured by Prix Pharmaceutica Pvt Ltd under strict cGMP protocols. Formulated for Livestock to provide consistent therapeutic efficacy and safety.
Select Pack Size
SKU: PRX-NEW-082-PK1 · Strength: As labeled
Marketed by Prix Pharmaceutica (Pvt) Ltd.
Overview
PRI-FLORECOL 23 ORAL LIQUID is a verified oral liquid developed and manufactured by Prix Pharmaceutica Pvt Ltd under strict cGMP protocols. Formulated for Livestock to provide consistent therapeutic efficacy and safety.
Administration Route
As directed on approved label
Dosage Form
oral liquid
Explore related Livestock solutions, our full product catalogue, and science and quality standards.
Composition
| Active Ingredient | Strength / Quantity |
|---|---|
| FUROSEMIDE (AS MONOETHANOLAMINE SALT) | 50MG |
| FLORFENICOL | 230GM |
| AS PER INNOVATOR''S SPECIFICATION EACH ML CONTAINS: | n/a |
Product information
Detailed product-use information is available from Prix Pharmaceutica technical support and on the approved product label.
For approved use details, please contact our technical team.
Dosage & Administration
Warnings & Precautions
For veterinary use only. Not for human use. Keep out of reach of children.
Withdrawal Period
Storage Instructions
Store below 25°C protected from direct sunlight
Packing
1 LITRE, 5 LITRE, 10 LITRE
Target species
Livestock
Product Documents
Contact Prix Pharmaceutica (Pvt) Ltd. for approved product literature and documentation.
⚠️ Safety Notice
For veterinary use only. Use according to approved product literature and under the guidance of a qualified veterinary professional.
Need guidance?
Our technical team can assist with product selection, dosage and programme development.
Technical Support📞 +92 42 36283464Product Specifications
- Product ID
- PRX-NEW-082
- Life Stages
- Adult, Young stock
- Manufacturing
- Marketed by Prix Pharmaceutica (Pvt) Ltd.
Responsible veterinary use
Product information is provided for professional veterinary reference. Follow the approved product label and consult a qualified veterinarian where appropriate.
Frequently asked questions about PRI-FLORECOL 23 ORAL LIQUID
Answers below reflect catalogue information only. Always follow the approved product label and qualified veterinary guidance.
What is PRI-FLORECOL 23 ORAL LIQUID?
Which dosage form is available for PRI-FLORECOL 23 ORAL LIQUID?
Which pack sizes are listed for PRI-FLORECOL 23 ORAL LIQUID?
Which animal category is PRI-FLORECOL 23 ORAL LIQUID listed under?
Where can product information for PRI-FLORECOL 23 ORAL LIQUID be requested?
How should the approved product label be followed?
Who should be consulted before veterinary use?
Related Products
Flushers / Diuretics
Filtrax
Registered poultry formulation
Filtrax is listed in the Prix Poultry Product Catalogue 2025 as a water-soluble powder in the flushers / diuretics range. Always follow the approved product label and qualified veterinary guidance.
Flushers / Diuretics
Urix
Registered poultry formulation
Urix is listed in the Prix Poultry Product Catalogue 2025 as a water-soluble powder in the flushers / diuretics range. Always follow the approved product label and qualified veterinary guidance.
Flushers / Diuretics
RENOMIDE INJECTION
Registered veterinary formulation (DRAP Reg: 125593)
RENOMIDE INJECTION is a verified injection developed and manufactured by Prix Pharmaceutica Pvt Ltd under strict cGMP protocols. Formulated for Livestock to provide consistent therapeutic efficacy and safety.
Flushers / Diuretics
RENOMIDE INJECTION
Registered veterinary formulation (DRAP Reg: 125594)
RENOMIDE INJECTION is a verified injection developed and manufactured by Prix Pharmaceutica Pvt Ltd under strict cGMP protocols. Formulated for Livestock to provide consistent therapeutic efficacy and safety.
Related insights
- Pakistan Veterinary Pharmaceutical Industry Outlook 2027: Regulatory Modernization, Market Dynamics, and Quality Standards
- Antimicrobial Stewardship in Livestock: Responsible Antibiotic Use, AMR Risks, and Herd Health in Pakistan
- Poultry Respiratory Disease Prevention and Farm Biosecurity in Pakistan: Clinical Insights for Commercial Broilers and Layers